Core Viewpoint - NAR Co., Ltd. plans to acquire at least 51% of Shanghai Feilai Testing Technology Co., Ltd. for an estimated transaction amount of 350 to 400 million yuan, aiming to enhance its strategic layout and business expansion in the semiconductor equipment sector [1][3]. Group 1: Acquisition Details - The acquisition involves NAR Co., Ltd. signing a share acquisition intention agreement with Shanghai Feiguang Management Consulting Partnership and Zhang Hua [1]. - The transaction is expected to provide NAR with control over Feilai Testing, a high-tech enterprise specializing in semiconductor chip testing reliability solutions [3]. Group 2: Company Profile of Feilai Testing - Feilai Testing is headquartered in Shanghai and has manufacturing bases in Wuxi and Nantong, recognized as a national-level "little giant" enterprise [3]. - The company offers a comprehensive range of solutions from wafer to device, including equipment like wafer AOI devices, chip testers, and aging systems, under its own brand "FeedLiTech" [3]. Group 3: Financial Projections - Feilai Testing is projected to achieve a revenue of 123 million yuan and a net profit of 1.9 million yuan in 2024, with further growth expected in 2025 [3]. - The performance commitment includes net profits of no less than 28 million yuan, 36 million yuan, and 48.2 million yuan for the years 2025 to 2027, totaling at least 112 million yuan [3]. Group 4: Strategic Implications - This acquisition reflects NAR's strategic shift from precision coating materials manufacturing to high-end equipment manufacturing and core semiconductor sectors, aiming to cultivate new growth drivers and enhance production capabilities [3].

Core Viewpoint - NAR Co., Ltd. plans to enter the semiconductor sector by acquiring at least 51% of Shanghai Feilai Testing Technology Co., Ltd. for approximately 350 million to 400 million yuan, which has led to a significant increase in its stock price [2][4][14]. Group 1: Acquisition Details - The acquisition involves a high premium, with Feilai Testing's total asset valuation at 750 million yuan, representing an increase of approximately 255.45% [3][6]. - Feilai Testing, established in May 2018, specializes in semiconductor chip testing reliability solutions and has already achieved profitability, reporting a net profit of 22.93 million yuan in the first half of 2025 [3][7][11]. - The transaction is expected to provide NAR with control over Feilai Testing, allowing it to enter the semiconductor equipment and components market [6][8]. Group 2: Financial Performance - NAR's revenue has shown growth from 549 million yuan in 2016 to 1.9 billion yuan in 2024, but the growth rate has been slow, with net profits also increasing at a sluggish pace [9]. - In the first half of 2025, NAR reported revenues of 972 million yuan and a net profit of 115 million yuan, marking a year-on-year increase of 4.10% and 79.15%, respectively [9][11]. - The company has previously attempted to find new growth avenues, including investments in other companies, but faced challenges with profitability in those ventures [10][11]. Group 3: Strategic Intent - The acquisition is part of NAR's strategy to create a second growth curve and overcome the limitations of its existing business model [5][12]. - The company aims to leverage this acquisition to explore new profit growth opportunities in the semiconductor industry [8][12].

Core Viewpoint - NAR Co., Ltd. plans to acquire at least 51% of Shanghai Feilai Testing Technology Co., Ltd. for an estimated amount of 350 to 400 million yuan, aiming to enhance its strategic layout and business expansion in the semiconductor equipment sector [1][3]. Group 1: Acquisition Details - The acquisition will not constitute a major asset restructuring, and there are no related party relationships involved [1]. - The investment is part of NAR's cross-industry investment initiative to enrich its industrial structure and enhance its capabilities in emerging business layouts [1][4]. Group 2: Target Company Overview - Feilai Testing specializes in semiconductor chip testing and reliability solutions, with main products including wafer AOI equipment, chip testers, aging systems, and automated loading and unloading equipment [3]. - The company has received various honors, including being recognized as a national-level "Little Giant" and a high-tech enterprise, and has accumulated 45 patent authorizations by the end of 2024 [3]. Group 3: Financial Performance and Projections - Feilai Testing is projected to achieve revenues of 123 million yuan and a net profit of 1.9 million yuan in 2024, with expected revenues of 92.46 million yuan and a net profit of 22.93 million yuan in the first half of 2025 [3]. - The profit commitments for 2025 to 2027 are set at no less than 28 million yuan, 36 million yuan, and 48.2 million yuan, totaling at least 112 million yuan [3]. Group 4: Strategic Implications - The acquisition is a significant step for NAR in implementing its strategy of "vigorously developing new quality productivity," allowing it to enter the semiconductor equipment and components field [3][4]. - NAR aims to leverage Feilai Testing's R&D capabilities and market resources to create new profit growth points and enhance efficiency across R&D, procurement, and sales systems [3][4].

Core Viewpoint - Nal Shares (002825) announced a share acquisition agreement with Shanghai Feiguang Management Consulting Partnership and Zhang Hua, aiming for a controlling stake in Shanghai Feilai Testing Technology Co., Ltd. with an investment amount estimated between RMB 350 million to 400 million [1] Group 1: Investment Details - The investment will result in the investors holding no less than 51% of the target company, thereby gaining control [1] - The overall valuation of the target company is estimated at RMB 750 million, with the final transaction price to be determined based on an assessment by a designated evaluation agency [1] Group 2: Company Profile - Shanghai Feilai Testing specializes in semiconductor chip testing reliability solutions, offering comprehensive solutions from wafers to devices, including various testing and aging equipment [1] - The company has received several honors, including being recognized as a national-level "specialized and innovative" small giant and a high-tech enterprise [1] Group 3: Financial Performance - For the fiscal year 2024, Shanghai Feilai Testing reported revenues of RMB 123 million and a net profit of RMB 1.9043 million [2] - In the first half of 2025, the company achieved revenues of RMB 92.4645 million and a net profit of RMB 2.29338 million [2] - The controlling shareholder has committed to achieving net profits of no less than RMB 28 million, 36 million, and 48.2 million for the years 2025 to 2027, totaling at least RMB 112.2 million [2]

Core Viewpoint - Nal Shares (002825) announced a plan to acquire a controlling stake in Shanghai Feilai Testing Technology Co., Ltd. through a share purchase agreement, with an estimated investment amount of approximately 350 to 400 million yuan [1] Group 1: Investment Details - The company intends to acquire at least 51% of Feilai Testing's shares, thereby gaining control over the target company [1] - The transaction amount is expected to be around 350 to 400 million yuan [1] Group 2: Company Profile - Feilai Testing specializes in semiconductor chip testing reliability solutions, offering comprehensive solutions from wafers and chips to devices [1] - The company provides various equipment including wafer AOI devices, chip testers, automatic loading and unloading equipment, aging systems, and COB testers, under its own brand "FeedLiTech" [1] Group 3: Financial Implications - Preliminary assessments indicate that Feilai Testing's revenue for 2024 will account for less than 50% of the listed company's total revenue [1] - Financial metrics such as total assets, net assets, and net profit do not meet the criteria for a significant asset restructuring as per the relevant regulations [1] - The counterparties in the investment agreement are not related parties to the listed company, thus the agreement does not constitute a related party transaction [1]

Core Viewpoint - NAR Co., Ltd. is acquiring a controlling stake in Feilai Testing Technology Co., Ltd. through a share purchase agreement, with an estimated transaction value of approximately 350 to 400 million yuan, which will enhance its industry layout and provide new growth opportunities in the semiconductor equipment sector [1][3]. Group 1: Investment Details - The investment will result in NAR holding at least 51% of Feilai Testing, thereby gaining control over the company [1]. - The expected revenue contribution from Feilai Testing to NAR's total revenue in 2024 is projected to be less than 50% [1]. - The financial metrics of Feilai Testing do not meet the criteria for a major asset restructuring as per regulatory standards [1]. Group 2: Feilai Testing Overview - Feilai Testing specializes in semiconductor chip testing reliability solutions, offering a comprehensive range of products including wafer AOI equipment and chip testers [2]. - The company has received multiple honors, including national-level "Little Giant" and high-tech enterprise designations, and holds 45 patents as of December 2024 [2]. - Feilai Testing's projected revenues for 2024 and the first half of 2025 are 123 million yuan and 92.46 million yuan, respectively, with net profits of 1.90 million yuan and 22.93 million yuan [2]. Group 3: Strategic Rationale - The acquisition aligns with NAR's strategic direction to diversify its business and leverage its financial stability and operational cash flow [3]. - NAR aims to enhance its presence in the semiconductor equipment sector, seeking new profit growth points through this acquisition [3]. - The company has prior indirect investment in Feilai Testing, providing it with foundational knowledge of the target's operations and market [3]. Group 4: Future Integration Plans - Post-acquisition, NAR plans to streamline Feilai Testing's management systems across sales, procurement, and R&D while ensuring operational stability [4]. - The integration aims to maximize resource utilization and achieve synergies in cost control, market expansion, and production technology [4]. - The goal is to enhance NAR's overall competitiveness through effective resource sharing and complementary advantages [4].

上海菲莱测试技术有限公司专注于半导体芯片测试可靠性解决方案，提供从晶圆、芯片到器件的全形态 方案，具体包括晶圆AOI设备、芯片测试机、COCO自动上下料设备、CoC老化系统、COB测试机、Soc 老化设备等，旗下拥有"FeedLiTech"自主品牌。公司总部及研发中心位于上海，在江苏无锡和南通分别 设有制造基地。公司分别获得国家级专精特新"小巨人"、高新技术企业、专精特新企业等荣誉。截止 2024年12月，已获得45项专利授权，其中实用新型29项、发明授权12项、外观设计4项。 格隆汇10月15日丨纳尔股份(002825.SZ)公布，公司与上海菲光管理咨询合伙企业（有限合伙）、张华 签订了《股权收购意向协议》，投资方以受让出售方所持上海菲莱测试技术有限公司（简称"目标公 司"）股权的方式投资目标公司。本次投资完成后，投资方将持有目标公司不低于51%的股权，取得目 标公司的控制权。具体受让股权比例在正式交易协议中明确，交易金额预计为人民币3.5亿至4亿元左 右。 ...

公告显示，上海菲莱测试技术有限公司专注于半导体芯片测试可靠性解决方案，提供从晶圆、芯片到器 件的全形态方案，具体包括晶圆AOI设备、芯片测试机、COCO自动上下料设备、CoC老化系统、COB 测试机、Soc老化设备等，旗下拥有"FeedLiTech"自主品牌。 通过本次交易，目标公司将成为上市公司的控股子公司，本次交易系上市公司按照"大力发展新质生产 力"的指引，以维稳主营和开发新领域为发展方向，尝试进入半导体设备、设备零部件等领域，以获得 新的利润增长点及发展机会。 智通财经APP讯，纳尔股份(002825.SZ)公告，公司作为投资方与上海菲光管理咨询合伙企业(有限合 伙)、张华签订了《股权收购意向协议》，投资方以受让出售方所持上海菲莱测试技术有限公司股权的 方式投资目标公司。投资完成后，投资方将持有目标公司不低于51%的股权，取得目标公司的控制权。 交易金额预计为人民币3.5亿至4亿元左右。 ...

纳尔股份公告，公司与上海菲光管理咨询合伙企业（有限合伙）、张华签订了《股权收购意向协议》， 投资方以受让出售方所持上海菲莱测试技术有限公司股权的方式投资目标公司。本次投资完成后，投资 方将持有目标公司不低于51%的股权，取得目标公司的控制权。交易金额预计为人民币3.5亿至4亿元左 右。上海菲莱测试技术有限公司专注于半导体芯片测试可靠性解决方案，提供从晶圆、芯片到器件的全 形态方案，具体包括晶圆AOI设备、芯片测试机、COCO自动上下料设备、CoC老化系统、COB测试 机、Soc老化设备等，旗下拥有"FeedLiTech"自主品牌。通过本次交易，目标公司将成为上市公司的控 股子公司。 ...

每经AI快讯，10月15日，纳尔股份（002825）(002825.SZ)公告称，公司与上海菲光管理咨询合伙企业 (有限合伙)、张华签订了《股权收购意向协议》，投资方以受让出售方所持上海菲莱测试技术有限公司 股权的方式投资目标公司。本次投资完成后，投资方将持有目标公司不低于51%的股权，取得目标公司 的控制权。交易金额预计为人民币3.5亿至4亿元左右。上海菲莱测试技术有限公司专注于半导体芯片测 试可靠性解决方案，提供从晶圆、芯片到器件的全形态方案，具体包括晶圆AOI设备、芯片测试机、 COCO自动上下料设备、CoC老化系统、COB测试机、Soc老化设备等，旗下拥有"FeedLiTech"自主品 牌。通过本次交易，目标公司将成为上市公司的控股子公司，本次交易系上市公司按照"大力发展新质 生产力"的指引，以维稳主营和开发新领域为发展方向，尝试进入半导体设备、设备零部件等领域，以 获得新的利润增长点及发展机会。 ...